Apparent anticipation in familial melanoma

被引:11
|
作者
Goldstein, AM
Clark, WH
Fraser, MC
Tucker, MA
机构
[1] Genetic Epidemiology Branch, Executive Plaza North, MSC 7372, Bethesda, MD 20892-7372
[2] Harvard Medical School, Department of Pathology, Beth Israel Hospital, Boston
[3] Pigmented Lesion Study Group, University of Pennsylvania, School of Medicine, Philadelphia
[4] Department of Nursing, Warren G. Magnuson Clinical Center, Bethesda
关键词
anticipation; familial melanoma; genetics;
D O I
10.1097/00008390-199612000-00006
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Genetic anticipation refers to progressively earlier age at diagnosis (AAD) and/or increasing severity of a disorder in successive generations. Previous examination of 23 familial melanoma kindreds revealed evidence for a dramatic reduction in AAD In successive generations. To further evaluate evidence for anticipation, we examined the AAD, number of tumours, and tumour thickness in affected parent-offspring (P-O) pairs from these 23 kindreds. Number of tumours and tumour thickness were also evaluated by generation. There were statistically significant intergenerational differences for AAD and number of tumours in the 47 affected P-O pairs. Median AAD decreased from 48 years to 28 years. The median AAD in the offspring (AAD,) of a parent with CMM (median 28, mean 29.3 +/- 10.1 years, n = 51) was significantly different from the median AAD, of a parent without CMM (42, 42.3 +/- 13.9 years, n = 55) (P < 0.001). In addition, parents with AAD less than the median of 48 years had offspring with a median AAD (26, 25.8 +/- 8.5 years, n = 21) significantly different from those of parents with AAD greater than or equal to 48 years (32, 34.5 +/- years, n = 26) (P = 0.005). Ninety-four percent (44/47) of the P-O pairs showed positive anticipation, with 62% showing anticipation of > 15 years. There was little difference based on the affected parent's sex. In the 106 CMM cases there were no significant differences in tumour number (P = 0.08) or tumour thickness (P = 0.85) by generation. Number of tumours was however significantly different in cases with AAD < 34 years (n = 52, median 1.5, mean 2.3 +/- 2.4) vs cases with AAD greater than or equal to 34 years (n = 54, 1.0, 1.6 +/- 1.7) (P < 0.001). Thus these 23 familial melanoma kindreds showed evidence for anticipation as defined by a decrease in AAD in successive generations. Although increased surveillance may partly explain the results, additional studies should evaluate melanoma risk factors, genetic and/or environmental, across generations to examine the reasons for the apparent anticipation.
引用
收藏
页码:441 / 446
页数:6
相关论文
共 50 条
  • [41] Does anticipation exist in familial pancreatic cancer?
    Julia B Greer
    David C Whitcomb
    Nature Clinical Practice Gastroenterology & Hepatology, 2006, 3 : 374 - 375
  • [42] Familial Crohn's disease: Is there genetic anticipation?
    Grandbastien, B
    Peeters, M
    Franchimont, D
    GowerRousseau, C
    Speckel, D
    Rutgeerts, P
    Belaiche, J
    Cortot, A
    Colombel, JF
    GASTROENTEROLOGY, 1996, 110 (04) : A917 - A917
  • [43] Identification of genetic anticipation in familial pancreatic cancer
    Kate Matthews
    Nature Clinical Practice Oncology, 2006, 3 (5): : 232 - 232
  • [44] More on disease anticipation in familial MPN - Response
    Landgren, Ola
    Goldin, Lynn R.
    Kristinsson, Sigurdur Y.
    Helgadottir, Elin A.
    Samuelsson, Jan
    Bjorkholm, Magnus
    BLOOD, 2008, 112 (06) : 2588 - 2588
  • [45] Familial melanoma and multiple primary melanoma
    De Simone, Paola
    Valiante, Michele
    Silipo, Vitaliano
    GIORNALE ITALIANO DI DERMATOLOGIA E VENEREOLOGIA, 2017, 152 (03): : 262 - 265
  • [46] FAMILIAL UVEAL MELANOMA
    BERCHER, L
    MUNIER, F
    ZOGRAFOS, L
    SCHORDERET, D
    EGGER, E
    CHAMOT, L
    KLINISCHE MONATSBLATTER FUR AUGENHEILKUNDE, 1995, 206 (05) : 384 - 387
  • [47] FAMILIAL UVEAL MELANOMA
    YOUNG, LHY
    EGAN, KM
    WALSH, SM
    GRAGOUDAS, ES
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 1994, 117 (04) : 516 - 520
  • [48] FAMILIAL UVEAL MELANOMA
    CANNING, CR
    HUNGERFORD, J
    BRITISH JOURNAL OF OPHTHALMOLOGY, 1988, 72 (04) : 241 - 243
  • [49] Management of familial melanoma
    Bishop, Julia Newton
    Harland, Mark
    Randerson-Moor, Juliette
    Bishop, D. Timothy
    LANCET ONCOLOGY, 2007, 8 (01): : 46 - 54
  • [50] Genetics Familial melanoma
    Cremin, Carol
    Blaine, Sean M.
    Allanson, Judith
    Dorman, Heather
    Gibbons, Clare A.
    Honeywell, Christina
    Meschino, Wendy S.
    Permaul, Joanne
    Carroll, June C.
    CANADIAN FAMILY PHYSICIAN, 2010, 56 (01) : 31 - 31